Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy - A feasibility and toxicity study

CBRT using IMRT improved boost coverage and lowered OAR doses, compared with SBT. Toxicities were acceptable using a daily boost of 3.28 Gy. While resource utilization was greater, overall treatment time was reduced.